Pharma & Healthcare
Global Central Nervous System (CNS) Therapeutics Market Research Report 2026
- May 01, 26
- ID: 748758
- Pages: 107
- Figures: 107
- Views: 17
This report delivers a comprehensive overview of the global Central Nervous System (CNS) Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Central Nervous System (CNS) Therapeutics. The Central Nervous System (CNS) Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Central Nervous System (CNS) Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Central Nervous System (CNS) Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
UCB Pharma
Viatris
Johnson and Johnson
Eli Lilly
Biogen
Roche
Merck & Co Inc
Takeda
Novartis
Teva
Segment by Type
Neurovascular Diseases
CNS Trauma
Neurodegenerative Diseases
Other
Segment by Application
Hospital
Online
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Central Nervous System (CNS) Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Central Nervous System (CNS) Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Central Nervous System (CNS) Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
UCB Pharma
Viatris
Johnson and Johnson
Eli Lilly
Biogen
Roche
Merck & Co Inc
Takeda
Novartis
Teva
Segment by Type
Neurovascular Diseases
CNS Trauma
Neurodegenerative Diseases
Other
Segment by Application
Hospital
Online
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Central Nervous System (CNS) Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Neurovascular Diseases
1.2.3 CNS Trauma
1.2.4 Neurodegenerative Diseases
1.2.5 Other
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Online
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutics Market Perspective (2021–2032)
2.2 Global Central Nervous System (CNS) Therapeutics Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Central Nervous System (CNS) Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Central Nervous System (CNS) Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Central Nervous System (CNS) Therapeutics Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutics Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutics Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutics Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutics Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Central Nervous System (CNS) Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Central Nervous System (CNS) Therapeutics Revenue
3.4 Global Central Nervous System (CNS) Therapeutics Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutics Revenue in 2025
3.5 Global Key Players of Central Nervous System (CNS) Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Central Nervous System (CNS) Therapeutics, Products and Applications
3.7 Global Key Players of Central Nervous System (CNS) Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutics Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Type (2027–2032)
5 Central Nervous System (CNS) Therapeutics Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
6.2 North America Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
6.4 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
7.2 Europe Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
7.4 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
9.2 Latin America Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCB Pharma
11.1.1 UCB Pharma Company Details
11.1.2 UCB Pharma Business Overview
11.1.3 UCB Pharma Central Nervous System (CNS) Therapeutics Introduction
11.1.4 UCB Pharma Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.1.5 UCB Pharma Recent Development
11.2 Viatris
11.2.1 Viatris Company Details
11.2.2 Viatris Business Overview
11.2.3 Viatris Central Nervous System (CNS) Therapeutics Introduction
11.2.4 Viatris Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.2.5 Viatris Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Central Nervous System (CNS) Therapeutics Introduction
11.3.4 Johnson and Johnson Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.3.5 Johnson and Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutics Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.4.5 Eli Lilly Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Central Nervous System (CNS) Therapeutics Introduction
11.5.4 Biogen Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.5.5 Biogen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Central Nervous System (CNS) Therapeutics Introduction
11.6.4 Roche Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.6.5 Roche Recent Development
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Company Details
11.7.2 Merck & Co Inc Business Overview
11.7.3 Merck & Co Inc Central Nervous System (CNS) Therapeutics Introduction
11.7.4 Merck & Co Inc Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.7.5 Merck & Co Inc Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Central Nervous System (CNS) Therapeutics Introduction
11.8.4 Takeda Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.8.5 Takeda Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Central Nervous System (CNS) Therapeutics Introduction
11.9.4 Novartis Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.9.5 Novartis Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Central Nervous System (CNS) Therapeutics Introduction
11.10.4 Teva Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.10.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Neurovascular Diseases
1.2.3 CNS Trauma
1.2.4 Neurodegenerative Diseases
1.2.5 Other
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Online
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutics Market Perspective (2021–2032)
2.2 Global Central Nervous System (CNS) Therapeutics Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Therapeutics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Central Nervous System (CNS) Therapeutics Historic Market Size by Region (2021–2026)
2.2.3 Central Nervous System (CNS) Therapeutics Forecasted Market Size by Region (2027–2032)
2.3 Central Nervous System (CNS) Therapeutics Market Dynamics
2.3.1 Central Nervous System (CNS) Therapeutics Industry Trends
2.3.2 Central Nervous System (CNS) Therapeutics Market Drivers
2.3.3 Central Nervous System (CNS) Therapeutics Market Challenges
2.3.4 Central Nervous System (CNS) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutics Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Therapeutics Players by Revenue (2021–2026)
3.1.2 Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Players (2021–2026)
3.2 Global Top Central Nervous System (CNS) Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Central Nervous System (CNS) Therapeutics Revenue
3.4 Global Central Nervous System (CNS) Therapeutics Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutics Revenue in 2025
3.5 Global Key Players of Central Nervous System (CNS) Therapeutics Head Offices and Areas Served
3.6 Global Key Players of Central Nervous System (CNS) Therapeutics, Products and Applications
3.7 Global Key Players of Central Nervous System (CNS) Therapeutics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Therapeutics Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Therapeutics Historic Market Size by Type (2021–2026)
4.2 Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Type (2027–2032)
5 Central Nervous System (CNS) Therapeutics Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Therapeutics Historic Market Size by Application (2021–2026)
5.2 Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
6.2 North America Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
6.4 North America Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
7.2 Europe Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
7.4 Europe Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
8.2 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (2021–2026)
8.4 Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
9.2 Latin America Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
9.4 Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size (2021–2032)
10.2 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2021–2026)
10.4 Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCB Pharma
11.1.1 UCB Pharma Company Details
11.1.2 UCB Pharma Business Overview
11.1.3 UCB Pharma Central Nervous System (CNS) Therapeutics Introduction
11.1.4 UCB Pharma Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.1.5 UCB Pharma Recent Development
11.2 Viatris
11.2.1 Viatris Company Details
11.2.2 Viatris Business Overview
11.2.3 Viatris Central Nervous System (CNS) Therapeutics Introduction
11.2.4 Viatris Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.2.5 Viatris Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Central Nervous System (CNS) Therapeutics Introduction
11.3.4 Johnson and Johnson Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.3.5 Johnson and Johnson Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutics Introduction
11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.4.5 Eli Lilly Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Central Nervous System (CNS) Therapeutics Introduction
11.5.4 Biogen Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.5.5 Biogen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Central Nervous System (CNS) Therapeutics Introduction
11.6.4 Roche Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.6.5 Roche Recent Development
11.7 Merck & Co Inc
11.7.1 Merck & Co Inc Company Details
11.7.2 Merck & Co Inc Business Overview
11.7.3 Merck & Co Inc Central Nervous System (CNS) Therapeutics Introduction
11.7.4 Merck & Co Inc Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.7.5 Merck & Co Inc Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Central Nervous System (CNS) Therapeutics Introduction
11.8.4 Takeda Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.8.5 Takeda Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Central Nervous System (CNS) Therapeutics Introduction
11.9.4 Novartis Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.9.5 Novartis Recent Development
11.10 Teva
11.10.1 Teva Company Details
11.10.2 Teva Business Overview
11.10.3 Teva Central Nervous System (CNS) Therapeutics Introduction
11.10.4 Teva Revenue in Central Nervous System (CNS) Therapeutics Business (2021–2026)
11.10.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Neurovascular Diseases
Table 3. Key Players of CNS Trauma
Table 4. Key Players of Neurodegenerative Diseases
Table 5. Key Players of Other
Table 6. Global Central Nervous System (CNS) Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2021–2026)
Table 10. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2027–2032)
Table 12. Central Nervous System (CNS) Therapeutics Market Trends
Table 13. Central Nervous System (CNS) Therapeutics Market Drivers
Table 14. Central Nervous System (CNS) Therapeutics Market Challenges
Table 15. Central Nervous System (CNS) Therapeutics Market Restraints
Table 16. Global Central Nervous System (CNS) Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Central Nervous System (CNS) Therapeutics Market Share by Players (2021–2026)
Table 18. Global Top Central Nervous System (CNS) Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Central Nervous System (CNS) Therapeutics Revenue, 2025
Table 19. Ranking of Global Top Central Nervous System (CNS) Therapeutics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Central Nervous System (CNS) Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Central Nervous System (CNS) Therapeutics, Products and Applications
Table 23. Global Key Players of Central Nervous System (CNS) Therapeutics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Central Nervous System (CNS) Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2021–2026)
Table 27. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2027–2032)
Table 29. Global Central Nervous System (CNS) Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2021–2026)
Table 31. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2027–2032)
Table 33. North America Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 48. UCB Pharma Company Details
Table 49. UCB Pharma Business Overview
Table 50. UCB Pharma Central Nervous System (CNS) Therapeutics Product
Table 51. UCB Pharma Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 52. UCB Pharma Recent Development
Table 53. Viatris Company Details
Table 54. Viatris Business Overview
Table 55. Viatris Central Nervous System (CNS) Therapeutics Product
Table 56. Viatris Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 57. Viatris Recent Development
Table 58. Johnson and Johnson Company Details
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Central Nervous System (CNS) Therapeutics Product
Table 61. Johnson and Johnson Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 62. Johnson and Johnson Recent Development
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Central Nervous System (CNS) Therapeutics Product
Table 66. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 67. Eli Lilly Recent Development
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Central Nervous System (CNS) Therapeutics Product
Table 71. Biogen Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 72. Biogen Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Central Nervous System (CNS) Therapeutics Product
Table 76. Roche Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 77. Roche Recent Development
Table 78. Merck & Co Inc Company Details
Table 79. Merck & Co Inc Business Overview
Table 80. Merck & Co Inc Central Nervous System (CNS) Therapeutics Product
Table 81. Merck & Co Inc Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 82. Merck & Co Inc Recent Development
Table 83. Takeda Company Details
Table 84. Takeda Business Overview
Table 85. Takeda Central Nervous System (CNS) Therapeutics Product
Table 86. Takeda Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 87. Takeda Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Central Nervous System (CNS) Therapeutics Product
Table 91. Novartis Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 92. Novartis Recent Development
Table 93. Teva Company Details
Table 94. Teva Business Overview
Table 95. Teva Central Nervous System (CNS) Therapeutics Product
Table 96. Teva Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 97. Teva Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Central Nervous System (CNS) Therapeutics Picture
Figure 2. Global Central Nervous System (CNS) Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Central Nervous System (CNS) Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. Neurovascular Diseases Features
Figure 5. CNS Trauma Features
Figure 6. Neurodegenerative Diseases Features
Figure 7. Other Features
Figure 8. Global Central Nervous System (CNS) Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Central Nervous System (CNS) Therapeutics Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Online Case Studies
Figure 12. Other Case Studies
Figure 13. Central Nervous System (CNS) Therapeutics Report Years Considered
Figure 14. Global Central Nervous System (CNS) Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Central Nervous System (CNS) Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Central Nervous System (CNS) Therapeutics Market Share by Region: 2025 vs 2032
Figure 17. Global Central Nervous System (CNS) Therapeutics Market Share by Players in 2025
Figure 18. Global Central Nervous System (CNS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutics Revenue in 2025
Figure 20. North America Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 22. United States Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 26. Germany Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Share by Region (2021–2032)
Figure 34. China Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 42. Mexico Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 46. Israel Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UCB Pharma Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 50. Viatris Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 51. Johnson and Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 52. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 53. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 54. Roche Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 55. Merck & Co Inc Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 56. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 57. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 58. Teva Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Neurovascular Diseases
Table 3. Key Players of CNS Trauma
Table 4. Key Players of Neurodegenerative Diseases
Table 5. Key Players of Other
Table 6. Global Central Nervous System (CNS) Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 9. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2021–2026)
Table 10. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Central Nervous System (CNS) Therapeutics Market Share by Region (2027–2032)
Table 12. Central Nervous System (CNS) Therapeutics Market Trends
Table 13. Central Nervous System (CNS) Therapeutics Market Drivers
Table 14. Central Nervous System (CNS) Therapeutics Market Challenges
Table 15. Central Nervous System (CNS) Therapeutics Market Restraints
Table 16. Global Central Nervous System (CNS) Therapeutics Revenue by Players (US$ Million), 2021–2026
Table 17. Global Central Nervous System (CNS) Therapeutics Market Share by Players (2021–2026)
Table 18. Global Top Central Nervous System (CNS) Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Central Nervous System (CNS) Therapeutics Revenue, 2025
Table 19. Ranking of Global Top Central Nervous System (CNS) Therapeutics Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutics Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Central Nervous System (CNS) Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Central Nervous System (CNS) Therapeutics, Products and Applications
Table 23. Global Key Players of Central Nervous System (CNS) Therapeutics, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Central Nervous System (CNS) Therapeutics Market Size by Type (US$ Million), 2021–2026
Table 26. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2021–2026)
Table 27. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Type (2027–2032)
Table 29. Global Central Nervous System (CNS) Therapeutics Market Size by Application (US$ Million), 2021–2026
Table 30. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2021–2026)
Table 31. Global Central Nervous System (CNS) Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Central Nervous System (CNS) Therapeutics Revenue Market Share by Application (2027–2032)
Table 33. North America Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 35. North America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size by Country (US$ Million), 2027–2032
Table 48. UCB Pharma Company Details
Table 49. UCB Pharma Business Overview
Table 50. UCB Pharma Central Nervous System (CNS) Therapeutics Product
Table 51. UCB Pharma Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 52. UCB Pharma Recent Development
Table 53. Viatris Company Details
Table 54. Viatris Business Overview
Table 55. Viatris Central Nervous System (CNS) Therapeutics Product
Table 56. Viatris Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 57. Viatris Recent Development
Table 58. Johnson and Johnson Company Details
Table 59. Johnson and Johnson Business Overview
Table 60. Johnson and Johnson Central Nervous System (CNS) Therapeutics Product
Table 61. Johnson and Johnson Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 62. Johnson and Johnson Recent Development
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Central Nervous System (CNS) Therapeutics Product
Table 66. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 67. Eli Lilly Recent Development
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Central Nervous System (CNS) Therapeutics Product
Table 71. Biogen Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 72. Biogen Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Central Nervous System (CNS) Therapeutics Product
Table 76. Roche Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 77. Roche Recent Development
Table 78. Merck & Co Inc Company Details
Table 79. Merck & Co Inc Business Overview
Table 80. Merck & Co Inc Central Nervous System (CNS) Therapeutics Product
Table 81. Merck & Co Inc Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 82. Merck & Co Inc Recent Development
Table 83. Takeda Company Details
Table 84. Takeda Business Overview
Table 85. Takeda Central Nervous System (CNS) Therapeutics Product
Table 86. Takeda Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 87. Takeda Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Central Nervous System (CNS) Therapeutics Product
Table 91. Novartis Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 92. Novartis Recent Development
Table 93. Teva Company Details
Table 94. Teva Business Overview
Table 95. Teva Central Nervous System (CNS) Therapeutics Product
Table 96. Teva Revenue in Central Nervous System (CNS) Therapeutics Business (US$ Million), 2021–2026
Table 97. Teva Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Central Nervous System (CNS) Therapeutics Picture
Figure 2. Global Central Nervous System (CNS) Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Central Nervous System (CNS) Therapeutics Market Share by Type: 2025 vs 2032
Figure 4. Neurovascular Diseases Features
Figure 5. CNS Trauma Features
Figure 6. Neurodegenerative Diseases Features
Figure 7. Other Features
Figure 8. Global Central Nervous System (CNS) Therapeutics Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Central Nervous System (CNS) Therapeutics Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Online Case Studies
Figure 12. Other Case Studies
Figure 13. Central Nervous System (CNS) Therapeutics Report Years Considered
Figure 14. Global Central Nervous System (CNS) Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Central Nervous System (CNS) Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Central Nervous System (CNS) Therapeutics Market Share by Region: 2025 vs 2032
Figure 17. Global Central Nervous System (CNS) Therapeutics Market Share by Players in 2025
Figure 18. Global Central Nervous System (CNS) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutics Revenue in 2025
Figure 20. North America Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 22. United States Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 26. Germany Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutics Market Share by Region (2021–2032)
Figure 34. China Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 42. Mexico Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutics Market Share by Country (2021–2032)
Figure 46. Israel Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Central Nervous System (CNS) Therapeutics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UCB Pharma Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 50. Viatris Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 51. Johnson and Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 52. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 53. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 54. Roche Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 55. Merck & Co Inc Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 56. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 57. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 58. Teva Revenue Growth Rate in Central Nervous System (CNS) Therapeutics Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232